Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D6TB
|
|||
| Former ID |
DNC008317
|
|||
| Drug Name |
1-(oxazol-2-yl)-4-(piperidin-4-yl)butan-1-one
|
|||
| Synonyms |
CHEMBL270404
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H18N2O2
|
|||
| Canonical SMILES |
C1CNCCC1CCCC(=O)C2=NC=CO2
|
|||
| InChI |
1S/C12H18N2O2/c15-11(12-14-8-9-16-12)3-1-2-10-4-6-13-7-5-10/h8-10,13H,1-7H2
|
|||
| InChIKey |
PKVYQZQOXHRPTR-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 938222-90-3
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH). Bioorg Med Chem Lett. 2008 Mar 15;18(6):2109-13. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.